MARLBOROUGH, Mass., Nov. 26, 2017 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has signed a development
"We're very excited to partner with a company that places the same value on image quality and accuracy as we do here at Hologic," said Pete Valenti, Hologic's Division President, Breast and Skeletal Health Solutions. "The exceptional image quality and portability of Clarius's ultrasound system, coupled with our industry-leading deep learning algorithms, bring us one step closer to ensuring all women have access to the breast care they need and deserve."
Financial terms of the agreement were not disclosed.
Of the 1.5 billion women worldwide who are eligible for breast cancer screening, less than 5 percent of them actually receive these critical services. As a company primarily focused on improving women's health and well-being through early detection and treatment, Hologic is dedicated to increasing global access to accurate breast screening and biopsy solutions through research, education and cutting-edge innovations.
The Clarius system is one of the many breast and skeletal health solutions available for demonstration in Hologic's booth (#4705) at the 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) at McCormick Place in Chicago from November 26 to 30. For more information, please visit Hologic's booth or www.hologicrsna.com.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
Hologic is a trademark of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.
Founded by ultrasound innovators, Clarius Mobile Health aims to make ultrasound available to all clinicians. Our affordable handheld ultrasound scanners offer clinicians the freedom to use ultrasound anywhere they need it. Clarius Scanners are regulatory cleared for sale in more than 20 countries worldwide. For more information, visit www.clarius.me.
This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.
This information is not intended as a product solicitation or promotion where such activities are prohibited. For specific information on what products are available for sale in a particular country, please contact a local Hologic sales representative or write to firstname.lastname@example.org.
Jane Mazur 508.263.8764 (direct) 585.355.5978 (mobile) email@example.com
Michael Watts 858.410.8588 firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/hologic-signs-development-and-distribution-agreement-with-clarius-mobile-health-for-innovative-ultrasound-system-300561574.html
SOURCE Hologic, Inc.
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All